
Jose Nicolau, MD, PhD, discusses the results of his subanalysis of the VESALIUS-CV trial, examining secondary rather than first MACE.

Jose Nicolau, MD, PhD, is a professor at the University of São Paulo Medical School and senior investigator at the Heart Institute InCor.